Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Sell
48
OMCL Quote, Financials, Valuation and Earnings
Last price:
$35.02
Seasonality move
:
13.68%
Day range:
$33.89 - $35.31
52-week range:
$25.12 - $55.75
Dividend yield:
0%
P/E ratio:
129.67x
P/S ratio:
1.46x
P/B ratio:
1.32x
Volume:
808.2K
Avg. volume:
585.3K
1-year change:
19.77%
Market cap:
$1.6B
Revenue:
$1.1B
EPS (TTM):
$0.27
Analysts' Opinion
-
Consensus RatingOmnicell has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $51.00, Omnicell has an estimated upside of 45.67% from its current price of $35.01.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $36.00 representing 100% downside risk from its current price of $35.01.
Fair Value
-
According to the consensus of 8 analysts, Omnicell has 45.67% upside to fair value with a price target of $51.00 per share.
OMCL vs. S&P 500
-
Over the past 5 trading days, Omnicell has overperformed the S&P 500 by 4.75% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Omnicell does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Omnicell has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Omnicell reported revenues of $306.9M.
Earnings Growth
-
Omnicell has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Omnicell reported earnings per share of $0.34.
Enterprise value:
1.6B
EV / Invested capital:
--
Price / LTM sales:
1.46x
EV / EBIT:
4,736.18x
EV / Revenue:
1.44x
PEG ratio (5yr expected):
-3.94x
EV / Free cash flow:
11.83x
Price / Operating cash flow:
12.02x
Enterprise value / EBITDA:
17.72x
Gross Profit (TTM):
$471M
Return On Assets:
0.56%
Net Income Margin (TTM):
1.13%
Return On Equity:
1.04%
Return On Invested Capital:
0.72%
Operating Margin:
4.04%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.3B | $1.1B | $1.1B | $258.8M | $306.9M | |
| Gross Profit | $589M | $496.8M | $471M | $105.4M | $141.8M | |
| Operating Income | -$2.3M | -$34.9M | $337K | -$23.4M | $12.4M | |
| EBITDA | $96.8M | $60.7M | $90.1M | $359K | $34.6M | |
| Diluted EPS | $0.10 | -$0.45 | $0.27 | -$0.32 | $0.34 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $829.4M | $780.7M | $881.8M | $927.6M | $815.5M | |
| Total Assets | $1.8B | $2.1B | $2.2B | $2.2B | $2.1B | |
| Current Liabilities | $276.4M | $876.2M | $428.4M | $367.8M | $595.7M | |
| Total Liabilities | $857M | $995.8M | $1.1B | $1B | $877.6M | |
| Total Equity | $967.5M | $1.1B | $1.1B | $1.2B | $1.2B | |
| Total Debt | $467.2M | $488.2M | $566.6M | $569.7M | $340.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $77.8M | $181.1M | $187.7M | $38.4M | $56.3M | |
| Cash From Investing | -$58.7M | -$55M | -$52.8M | -$12.4M | -$13.6M | |
| Cash From Financing | -$21M | $23.4M | -$235.6M | $13.1M | -$234.4M | |
| Free Cash Flow | $17M | $126.1M | $134.9M | $26M | $42.7M | |
OMCL
Sector
Market Cap
$1.6B
$36.5M
Price % of 52-Week High
62.8%
44.66%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.9%
1-Year Price Total Return
19.77%
-39.9%
Beta (5-Year)
0.849
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$34.74
200-day SMA
Sell
Level
$39.80
Bollinger Bands (100)
Sell
Level
37.94 - 47.46
Chaikin Money Flow
Buy
Level
69M
20-day SMA
Sell
Level
$35.18
Relative Strength Index (RSI14)
Sell
Level
43.35
ADX Line
Sell
Level
30.07
Williams %R
Neutral
Level
-32.2275
50-day SMA
Sell
Level
$39.25
MACD (12, 26)
Sell
Level
-1.33
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
8.5M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3137)
Buy
CA Score
(Annual)
Level (0.0089)
Buy
Beneish M-Score
(Annual)
Level (-2.7477)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.8753)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
Stock Forecast FAQ
In the current month, OMCL has received 3 Buy ratings 5 Hold ratings, and 0 Sell ratings. The OMCL average analyst price target in the past 3 months is $51.00.
-
Where Will Omnicell Stock Be In 1 Year?
According to analysts, the consensus estimate is that Omnicell share price will rise to $51.00 per share over the next 12 months.
-
What Do Analysts Say About Omnicell?
Analysts are divided on their view about Omnicell share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Omnicell is a Sell and believe this share price will drop from its current level to $36.00.
-
What Is Omnicell's Price Target?
The price target for Omnicell over the next 1-year time period is forecast to be $51.00 according to 8 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is OMCL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Omnicell is a Hold. 5 of 8 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of OMCL?
You can purchase shares of Omnicell via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Omnicell shares.
-
What Is The Omnicell Share Price Today?
Omnicell was last trading at $35.02 per share. This represents the most recent stock quote for Omnicell. Yesterday, Omnicell closed at $35.01 per share.
-
How To Buy Omnicell Stock Online?
In order to purchase Omnicell stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Buffett Sell the S&P 500?
Warren Buffett has always been an advocate of investing in…
Will SoundHound AI Stock Recover?
SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
Sell
24
AIR alert for Mar 29
AAR [AIR] is down 16.36% over the past day.
